Transcription factors are the most powerful genes in our body. They are master regulators and have been implicated in our biggest diseases, even aging itself. Yet, many in the pharmaceutical industry ...

In this Q&A, Latent Labs CEO and AlphaFold co-developer Simon Kohl explains how generative A.I. is transforming biology from a science of prediction to one of design, why programmable drug ...

Researchers at Umeå University have identified a key molecular player that helps bacteria survive the hostile environment ...

This important study uses innovative microfluidics-based single-cell imaging to monitor replicative lifespan, protein localization, and intracellular iron levels in aging yeast cells. The evidence for ...

Intrinsically disordered regions in transcription factors enhance both target binding probability and search efficiency.

U.S. tech giants are facing a reckoning from the East. Even as Nvidia pledged today to invest a staggering $100 billion into its own customer OpenAI's data centers — a move that raised eyebrows across ...

While global headlines are dominated by trillion-dollar giants, one ASX small cap is quietly making big strides in artificial intelligence. AI-Media Technologies Ltd (ASX: AIM) has built its business ...

Researchers from the University of Chicago have discovered a way to turn a fluorescent protein into a biological qubit that can be built directly inside a cell, then used as a way to detect magnetic ...

Background With population ageing, elderly patients account for a growing proportion of hepatic surgery recipients. Hepatic ischaemia-reperfusion injury (HIRI) is a major cause of postoperative liver ...

Background The combination of atezolizumab and bevacizumab (ATZ/BVZ) therapy has significantly advanced therapeutic approaches for hepatocellular carcinoma (HCC). However, less than 30% of patients ...